AsthmaNCT03518879
ASTHMA-Educator Mobile Application Manage Asthma
A study testing ASTHMA-Educator mobile application in people with Asthma, run by Montefiore Medical Center at 1 site in United States.
Trial summary
Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use among adult asthma patients at Montefiore. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Asthma
- What is being tested?
- ASTHMA-Educator mobile application
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteUnited States
- Study dates
- Mar 2015to 1 Jul 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Inclusion Criteria: Adults (>18 years) with: (a) severe asthma (i.e. at least one asthma-related ED visit and/or hospitalization in the previous year); (b) access to a smartphone with short message service (SMS) capability; (c) English speaking; (d) able to give informed consent.
Exclusion Criteria: (a) use of oral corticosteroids in the 2 weeks prior to the baseline visit; (b) pregnancy; (c) severe psychiatric or cognitive problems that would prohibit an individual from understanding and completing the protocol; and (d) patients that previously received the ASTHMAXcel application.
Trial locations and contacts
1 site in 1 country.
United States1 site
Montefiore Medical Center
The Bronx, New York, 10467
About this study
Official title: The ASTHMA-Educator: A Novel Algorithmic Software Tool to Help Manage Asthma
Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use among adult asthma patients at Montefiore.
Read the detailed description
Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use through 2 phases: 1) Phase 1 = process outcomes evaluation with 30 patients); and 2) Phase 2 (longitudinal clinical evaluation with 40 patients receiving the intervention at baseline, 2 months, 4 months, and 6 months). The study's primary outcome is asthma control.
- Conditions
- Asthma
- Being tested
- ASTHMA-Educator mobile application
- Keywords
- informatics, asthma
- Medical subject headings
- Asthma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ASTHMA-Educator mobile applicationOther
The on-site delivered ASTHMA-Educator mobile application.
| Study group | Role | What they receive |
|---|---|---|
| ASTHMA-Educator arm | Experimental | The ASTHMA-Educator mobile application for patient-centered asthma education. The application is administered via on-site iPad (tablet). Receives: Other: ASTHMA-Educator mobile application |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline asthma control to 2, 4, and 6 months
Asthma symptom burden as measured by the Asthma Control Test
Measured: Baseline, 2 months, 4 months, 6 months
Secondary outcomes (7)
Change from baseline asthma knowledge to immediately post-intervention, 2 months, 4 months, and 6 months
Asthma knowledge as measured by the validated Asthma Knowledge Questionnaire
Measured: Baseline, immediately post-intervention, 2 months, 4 months, 6 months
Patient satisfaction measured by the Client Satisfaction Questionnaire-8
Patient satisfaction measured by the Client Satisfaction Questionnaire-8
Measured: Immediately post-intervention at the baseline visit, 2 months, 4 months, 6 months
Time spent in using the mobile application
Time spent in using the mobile application
Measured: Immediately post-intervention at the baseline visit
Asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ)
Patients' asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ)
Measured: Baseline, 2 months, 4 months, 6 months
Asthma emergency department visits
Asthma emergency department visits
Measured: Baseline, 2 months, 4 months, 6 months
Asthma hospitalizations
Asthma hospitalizations
Measured: Baseline, 2 months, 4 months, 6 months
Asthma-related steroid courses
Asthma-related steroid courses
Measured: Baseline, 2 months, 4 months, 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 May 2018
- Study startMar 2015
- Primary completion1 Jul 2021
- Study completion1 Jul 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AsthmaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- This is a single-arm proof of concept study to evaluate the impact of the ASTHMA-Educator on process and clinical outcomes
- Masking
- None (open label)
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Montefiore Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sunit Jariwala, Principal investigator, Montefiore Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03518879
- Sponsor's protocol ID
- 2013-2693
- Status last verified
- Jun 2023
- First submitted
- 13 Apr 2018
- Last updated
- 7 Jun 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: The investigators will share de-identified and aggregated study findings.
Study at a glance
From the registry record, last updated by the sponsor on 7 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The ASTHMA-Educator: A Novel Algorithmic Software Tool to Help Manage Asthma
- ClinicalTrials.gov ID
- NCT03518879
- Acronym / sponsor ID
- 2013-2693
- Conditions
- Asthma
- Keywords
- informatics, asthma
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Montefiore Medical CenterUniversity, hospital or other
- Study start
- Mar 2015 (actual)
- Primary completion
- 1 Jul 2021 (actual)
- Study completion
- 1 Jul 2021 (actual)
- First posted
- 8 May 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use among adult asthma patients at Montefiore.
Detailed description
Through this study, the investigators developed the ASTHMA-Educator mobile application, and evaluated its use through 2 phases: 1) Phase 1 = process outcomes evaluation with 30 patients); and 2) Phase 2 (longitudinal clinical evaluation with 40 patients receiving the intervention at baseline, 2 months, 4 months, and 6 months). The study's primary outcome is asthma control.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- This is a single-arm proof of concept study to evaluate the impact of the ASTHMA-Educator on process and clinical outcomes
| Arm | Type | Receives |
|---|---|---|
| ASTHMA-Educator arm | Experimental | Other: ASTHMA-Educator mobile applicationThe ASTHMA-Educator mobile application for patient-centered asthma education. The application is administered via on-site iPad (tablet). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ASTHMA-Educator mobile applicationThe on-site delivered ASTHMA-Educator mobile application. | Other | ASTHMA-Educator arm |
Primary outcome
Change from baseline asthma control to 2, 4, and 6 months
Time frame: Baseline, 2 months, 4 months, 6 months
Asthma symptom burden as measured by the Asthma Control Test
7 secondary outcomes
Change from baseline asthma knowledge to immediately post-intervention, 2 months, 4 months, and 6 months
Time frame: Baseline, immediately post-intervention, 2 months, 4 months, 6 months
Patient satisfaction measured by the Client Satisfaction Questionnaire-8
Time frame: Immediately post-intervention at the baseline visit, 2 months, 4 months, 6 months
Time spent in using the mobile application
Time frame: Immediately post-intervention at the baseline visit
Asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ)
Time frame: Baseline, 2 months, 4 months, 6 months
Asthma emergency department visits
Time frame: Baseline, 2 months, 4 months, 6 months
Asthma hospitalizations
Time frame: Baseline, 2 months, 4 months, 6 months
Asthma-related steroid courses
Time frame: Baseline, 2 months, 4 months, 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jun 2023.
- Individual participant dataSharing planned: Undecided. The investigators will share de-identified and aggregated study findings.
Related trials for Asthma
RecruitingObservational study
Asthma and Primary Arterial Hypertension: an Inflammatory Link?
Asthma Bronchial
RecruitingPhase 3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
Asthma
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
RecruitingPhase 2
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Asthma
Active, not recruitingPhase 1
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Asthma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sunit Jariwala principal investigator
Montefiore Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ASTHMA-Educator mobile application in people with Asthma, run by Montefiore Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline asthma control to 2, 4, and 6 months (time frame: Baseline, 2 months, 4 months, 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2023.